Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 377 of 673

Advanced search

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

ICBs funded for independent prescribing implementation

The Pharmaceutical JournalOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

WHO Begins Trial for Ebola Outbreak

LabrootsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial

Yahoo FinanceOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

C16 Biosciences builds palm-free beauty toolkit with biotech ingredient trio

Personal Care InsightsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline

BenzingaOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Psychedelics Gain Momentum in Big Pharma

LabrootsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

July 2026 in Pain Management: 10 Developments That Advanced and Challenged Patient Care

Pharmacy TimesOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Sweat-Proof Wearable Sensors Offer Better Health Tracking

LabrootsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Stock Is Sinking Friday: What's Going On?

BenzingaOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

July 2026 in Hematology: 15 Developments That Advanced—and Challenged—Patient Care

Pharmacy TimesOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Aug 1discoverynews.google.comTier 2 · Trade media

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

Pharmaceutical TechnologyOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

FDA Tentative Approval for Omcazio: A New Cabozantinib Capsule Formulation

Oncology Nursing NewsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Ziltivekimab Fails to Reduce Cardiovascular Events in Phase 3 ZEUS Trial

BioPharm InternationalOriginal source

🌍Aug 1Regulatorycssp.gob.svTier 1 · Regulatory source

Acto de juramentación de nuevos miembros del Consejo Directivo y Junta de Vigilancias

Consejo Superior de Salud Pública (El Salvador)Original source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

FDA clears autoinjector drug for home treatment of heart failure edema

Cardiovascular BusinessOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Presentation: Paradigm Biopharma - Ignite Investment Summit, Hong Kong, April 2026 Raj Bawa (mt2uB4xSQj)

MshaleOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Drops 5.9% Amid Sector-Wide Selling

news.alphastreet.comOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

FDA weighs in on peptides, VA tests new use for popular drug and wildfire smoke returns

WKYCOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

IOVA Stock Slides As Biotech Traders Watch Key Support

StocksToTradeOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

FDA approves long-lasting OTC pain reliever combining acetaminophen and naproxen

KZTV10Original source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

ZEUS failure clouds future of Novo’s cardiovascular plans

European Biotechnology MagazineOriginal source

🌍Aug 1Regulatorycssp.gob.svTier 1 · Regulatory source

Acto de juramentación de nuevos miembros del Consejo Directivo y Junta de Vigilancias

Consejo Superior de Salud Pública (El Salvador)Original source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Biotech is Back: A Wave of Life Science Deals is Pumping Cash into the Sector

foleyhoag.comOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Why Onshoring Alone Won't Secure Pharma Supply Chains

Pharmaceutical CommerceOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Taisho Pharmaceutical licenses Kaigene’s KG006 for Japan autoimmune drug push

International Business TimesOriginal source

🌍Aug 1discoverynews.google.comTier 2 · Trade media

Novo setback casts doubt on a new way to treat heart disease

BioPharma DiveOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Karnataka Bans Sale Of Junk Food In Schools, Colleges And Within 50-Metre Radius

The Bengaluru LiveOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

George Mason licenses cancer imaging technology to biotech company

George Mason UniversityOriginal source

🇺🇸Aug 1Devicesorthopediatrics.comTier 1 · Company source

ORTHEX Small Bone Circular Fixator

OrthoPediatricsOriginal source

🌍Aug 1discoverynews.google.comTier 3 · Aggregated media

Definium’s LSD phase III win caps a strong June for CNS therapies

BioWorld NewsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

This Week in Boomtown: Aviation industry in Ohio; affordable housing; future of biotech

10TVOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Sleep-Apnea Biotech Apnimed Shares Jump After Upsized US IPO

Bloomberg.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

FDA Supports Bayesian Statistics: Leap Forward or New Bias?

medscape.comOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Novo’s IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%

BioSpaceOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics (NASDAQ: TENX) ends Q2 2026 with $118M cash

stocktitan.netOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

The West Must Confront China’s Biotech Offensive

Center for European Policy Analysis (CEPA)Original source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Biotech Produces Ebola Proteins in Just 15 Days as African Outbreak Intensifies

Streetwise ReportsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial

Proactive financial newsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Protect Pharmaceutical Corp – OTC:PRTT

TradingViewOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Maharashtra schools to junk vad pav, chips, energy drinks: The new food safety norms

India TodayOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals

RTTNewsOriginal source

🇺🇰Jul 31Regulatorygov.ukTier 1 · Regulatory source

Immunoglobulin: when to use

UK Health Security Agency's immunoglobulin handbook, providing guidance on administering immunoglobu...

UK Health Security AgencyOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk stock tumbles 10% as key trial misses goal

Investing.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Milind Deora Urges FSSAI To Replicate Tukaram Mundhe-Led Maharashtra FDA's Crackdown Nationwide; Here's Why

latestly.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Silicon Valley Looks to a New Biotech Frontier: Montana

The InformationOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

‘It’s a peptide wild west’: how RFK Jr is clearing way for a market of untested drugs

The GuardianOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Acute kidney injury: causes, diagnosis and management

The Pharmaceutical JournalOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.46, Implies 13% Upside

TradingViewOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Prices $9.3 Million Best-Efforts Public Offering with Warrants

Quiver QuantitativeOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech prices $9.3 million public offering

Investing.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Appeals court says Iowa vape law does not conflict with FDA rules

The Des Moines RegisterOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Bombay HC, FDA commissioner Tukaram Munde clash over hygiene checks at eateries

The New Indian ExpressOriginal source

🇺🇰Jul 31Regulatorygov.ukTier 1 · Regulatory source

Malaria prevention guidelines for travellers from the UK 2026

The UK Malaria Expert Advisory Group (formerly the Advisory Committee on Malaria Prevention) updates...

UK Health Security AgencyOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis

Fierce PharmaOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech earnings in focus as Vyjuvek expansion accelerates

Investing.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Vanguard Capital Management (COLL) discloses 5.01% passive stake in Collegium

Stock TitanOriginal source

🇺🇰Jul 31Regulatorygov.ukTier 1 · Regulatory source

Government takes action to crack down on rogue funeral operators

Urgent work to take place to protect bereaved families.

UK Department of Health and Social CareOriginal source

🇫🇷Jul 31Researchchru-strasbourg.frTier 2 · Direct publisher

Travaux des accès au CMCO de Schiltigheim

Hôpitaux Universitaires de StrasbourgOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Pharmalittle: We're reading about a Novo setback, support for Replimune's melanoma drug, and more

STATOriginal source